The challenges A key hurdle facing outcome teams as with the entire pharmaceutical industry is non-adherence by patients to medication. This problem is only likely to be surmounted if patients believe that taking medication will lead to immediate benefits through… Read More ›
secondary endpoints
The Diabetes Health Profile: Using PRO Measures to Support Endpoints
View our latest presentation on PRO endpoints at PRO/COA Conference, Philadelphia 6th March Procoa philadelphia summit” target=”_blank”>Procoa philadelphia summit from Keith Meadows
Selecting the Appropriate PRO for your Clinical Trial: A Training Workshop
Both nationally and internationally, the assessment of outcomes based on the patient’s perspective using patient-reported outcome (PRO) measures, are increasingly accompanying the traditional clinical ways of measuring health and the effects of treatment on the patient. Data derived from PROs… Read More ›
